Concepedia

Matthew I. Milowsky

MI

144

Publications

14.1K

Citations

58

H-Index

2002

Active since

Affiliations

University of North Carolina at Chapel Hill(Current)

Memorial Sloan Kettering Cancer Center

UNC Lineberger Comprehensive Cancer Center

Cornell University

Dana-Farber Cancer Institute

Matthew I. Milowsky is an author at University of North Carolina at Chapel Hill specializing in medicine, oncology, and urology.

ORCID

Top concepts

Publications per year

2002–2025

144

Publications

144

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma

Dean F. Bajorin, J. Alfred Witjes, Jürgen E. Gschwend et al. · New England Journal of Medicine · 2021 · 968 citations · Full text

Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology

Jeffrey S. Damrauer, Katherine A. Hoadley, David D. Chism et al. · Proceedings of the National Academy of Sciences · 2014 · 876 citations · Full text

Genome Sequencing Identifies a Basis for Everolimus Sensitivity

Gopa Iyer, Aphrothiti J. Hanrahan, Matthew I. Milowsky et al. · Science · 2012 · 684 citations · Full text

, , +18

Phase I Trial of <sup>177</sup>Lutetium-Labeled J591, a Monoclonal Antibody to Prostate-Specific Membrane Antigen, in Patients With Androgen-Independent Prostate Cancer

Neil H. Bander, Matthew I. Milowsky, David M. Nanus et al. · Journal of Clinical Oncology · 2005 · 504 citations

Phase II Study of Lutetium-177–Labeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-Resistant Prostate Cancer

Scott T. Tagawa, Matthew I. Milowsky, Michael J. Morris et al. · Clinical Cancer Research · 2013 · 414 citations · Full text

Rows per page

1–5 of 144